Photo of Vivien Yin

View Scopus Profile

Vivien Yin, PhD

  • 281 Citations
  • 9 Scopus h-Index
20112020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vivien Yin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 281 Citations
  • 9 Scopus h-Index
  • 22 Article
  • 1 Review article

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Salem, M. E., Yin, J., Goldberg, R. M., Pederson, L. D., Wolmark, N., Alberts, S. R., Taieb, J., Marshall, J. L., Lonardi, S., Yoshino, T., Kerr, R. S., Yothers, G., Grothey, A. F., Andre, T., De Gramont, A. & Shi, Q., Apr 2020, In : Annals of Oncology. 31, 4, p. 480-486 7 p.

Research output: Contribution to journal › Article

    • 1 Scopus citations

    An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cycles

    Du, Y., Yin, J., Sargent, D. J. & Mandrekar, S. J., Mar 4 2019, In : Journal of Biopharmaceutical Statistics. 29, 2, p. 271-286 16 p.

    Research output: Contribution to journal › Article

    • A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

    Xie, H., Yin, J., Shah, M. H., Menefee, M. G., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A. A., Aug 15 2019, In : Investigational New Drugs. 37, 4, p. 755-762 8 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors

    Jazieh, K., Molina, J., Allred, J., Yin, J., Reid, J., Goetz, M., Lim, V. S., Kaufmann, S. H. & Adjei, A., Apr 15 2019, In : Investigational New Drugs. 37, 2, p. 307-314 8 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

    Ruppert, A. S., Yin, J., Davidian, M., Tsiatis, A. A., Byrd, J. C., Woyach, J. A. & Mandrekar, S. J., 2019, In : Annals of Oncology. 30, 4, p. 542-550 9 p., mdz053.

    Research output: Contribution to journal › Review article

    Open Access